Exemplifying the case of CD19-positive ALL, instances have arisen wherein point mutations within the CD19 gene have led to the production of a truncated protein, characterized by either a nonfunctional or entirely absent transmembrane domain [15, 18]. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.